Journal article
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
- Abstract:
-
BACKGROUND: As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the trials of 5 years of adjuvant tamoxifen. METHODS: We undertook a collaborative meta-analysis of individual patient data from 20 trials (n=21,457) in early breast cancer of about 5 years of tamoxifen versus no adjuvant tamoxifen, with abou...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 511.2KB)
-
- Publisher copy:
- 10.1016/s0140-6736(11)60993-8
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Journal website
- Volume:
- 378
- Issue:
- 9793
- Pages:
- 771-784
- Publication date:
- 2011-08-01
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Source identifiers:
-
175541
Item Description
- Language:
- English
- Keywords:
- UUID:
-
uuid:0ade6b6d-0d69-4dc4-913d-e008d5e4be5c
- Local pid:
- pubs:175541
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2011
- Notes:
- Copyright 2011 Elsevier Ltd. All rights reserved. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://www.elsevier.com/open-access/userlicense/1.0/
If you are the owner of this record, you can report an update to it here: Report update to this record